Literature DB >> 3157145

[Colonic cancers. Results of surgical treatment and prognosis. 579 cases].

J Moreaux, M Catala.   

Abstract

Between 1964 and 1981, 579 patients were operated upon for carcinoma of the colon. Hepatic and/or peritoneal metastases were present in 17.3%. Excision was performed in 530 cases (91.5%). Carcinomas of the left colon were usually treated by segmental resection. The peritoneum and lymph nodes were involved in 21.7% and 31% respectively of the patients who underwent resection. There were 6 post-operative deaths: 2 after exploratory or derivative surgery and 4 after excision of the tumour. All but 8 of the 395 patients operated upon before 1978 were followed up; 229 survived for more than 5 years, 58% of all operated patients and 63.6% of those who had their tumour excised. The 5-year survival rate was 6% after palliative excision and 73.6% after curative excision (caecum and ascending colon: 81%; transverse colon: 83%; descending colon: 65%; sigmoid flexure: 70.7%). Tumoral invasion in depth and lymph node involvement had a significant influence on prognosis. Based on Dukes' classification, the 5-year survival rates for stages A, B, C and D tumours were 89%, 75.4%, 54% and 6% respectively. The time elapsed between the first symptoms and the operation did not alter the prognosis which was slightly better in women and in young patients.

Entities:  

Mesh:

Year:  1985        PMID: 3157145

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  2 in total

1.  Single-layer anastomosis in surgery of the large bowel. A prospective study on 316 cases in a university hospital.

Authors:  P Frileux; M A Quilichini; E Tiret; B Nordlinger; L Hannoun; R Parc; J Loygue
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

Review 2.  Surgery for carcinoma of the colon in people aged 75 years and older.

Authors:  J P Ozoux; L de Calan; M Perrier; C Berton; J P Favre; J Brizon
Journal:  Int J Colorectal Dis       Date:  1990-02       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.